BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
BiPER Therapeutics has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
BiPER Therapeutics's investors include Bpifrance, Medin Fund Management Co, WiSEED, Région Grand Est.
BiPER Therapeutics is headquartered in Strasbourg, France.
BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
BiPER Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BiPER Therapeutics — Funding & Investors." VCBacked, December 2, 2025, https://www.vcbacked.co/company/biper-therapeutics. Accessed October 29, 2026.
VCBacked. (2025). BiPER Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/biper-therapeutics
{{cite web |title=BiPER Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/biper-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated